LONG MINI-FUTURE - BIOGEN IDEC | Market Closed - Deutsche Boerse AG 01:53:18 2024-05-24 pm EDT | ||
| 3.63 EUR | -1.63% |
|
| Current month | -0.55% | ||
| 1 month | +65.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-24 | 3.63 | -1.63% |
| 24-05-23 | 3.69 | -17.08% |
| 24-05-22 | 4.45 | +0.23% |
| 24-05-21 | 4.44 | -10.48% |
| 24-05-20 | 4.96 | +5.08% |
Delayed Quote Deutsche Boerse AG
Last update May 24, 2024 at 01:53 pm EDT
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VV5K3Y |
| ISIN | DE000VV5K3Y3 |
| Date issued | 2022-07-19 |
| Strike | 179 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 6.32 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.78 € |
|---|---|
| Lowest since issue | 1.19 € |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
217.8
USD
Average target price
286.1
USD
Spread / Average Target
+31.33%
- Stock Market
- Certificates
- Certificat
